经23G微创巩膜切口睫状体光凝术治疗难治性青光眼
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Cyclophotocoagulation through 23G minimally invasive scleral incision treating refractory glaucoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察经23G微创巩膜切口睫状体光凝术治疗难治性青光眼的疗效及其安全性。

    方法:对23例23眼难治性青光眼患者采用经23G微创巩膜切口睫状体光凝,观察术后眼压、最佳矫正视力、降眼压药物数量、并发症情况。

    结果:手术后眼压、最佳矫正视力及降眼压药物数量与术前相比,差异有统计学意义(P<0.05); 术后并发症少。

    结论:经23G微创巩膜切口睫状体光凝术是一种新型且安全有效的治疗难治性青光眼的手术方法。

    Abstract:

    AIM: To observe the efficacy and safety of cyclophoto-coagulation through 23G minimally invasive scleral incision in the treatment of refractory glaucoma.

    METHODS: Totally 23 patients(23 eyes)were taken the surgery-the cyclophotocoagulation-through 23G minimally invasive scleral incision. We observed the changes of intraocular pressure(IOP), the best corrected visual acuity(BCVA), the quantity of drugs reducing intraocular pressure and complications in the pre-and post-operation.

    RESLUTS: Comparing with preoperative, the postopera-tive IOP, BCVA and the number of IOP-decreased drugs were statistically significant(P<0.05); the complication was fewer.

    CONCLUSION: The 23G minimally invasive scleral incision cyclophotocoagulation is a new type of safe and effective surgical method for the treatment of refractory glaucoma.

    参考文献
    相似文献
    引证文献
引用本文

侯盼,邝国平.经23G微创巩膜切口睫状体光凝术治疗难治性青光眼.国际眼科杂志, 2017,17(2):338-340.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-10-13
  • 最后修改日期:2016-12-30
  • 录用日期:
  • 在线发布日期: 2017-01-20
  • 出版日期:
文章二维码